Beyond exposure-response: A tutorial on statistical considerations in dose-ranging studies

被引:4
作者
Laird, Glen [1 ]
Xu, Lei [1 ]
Liu, Meng [1 ]
Liu, Jin [1 ]
机构
[1] Vertex Pharmaceut Inc, 50 Northern Ave, Boston, MA 02210 USA
来源
CTS-CLINICAL AND TRANSLATIONAL SCIENCE | 2021年 / 14卷 / 04期
关键词
EFFICACY;
D O I
10.1111/cts.12998
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Dose-ranging studies are a crucial part of the phase II drug development process. They complement the understanding gained from exposure-response analyses. However, the statistical design issues related to dose-ranging studies are not always keenly understood and a poorly designed study can be costly for later development. In this tutorial, we review five key statistical principles in designing such a study. We also describe some popular statistical approaches, including pairwise comparison, modeling, and Multiple Comparison Procedure modeling in the context of principles.
引用
收藏
页码:1250 / 1258
页数:9
相关论文
共 20 条
[1]  
Bornkamp B., 2018, **DATA OBJECT**
[2]   Combining multiple comparisons and modeling techniques in dose-response studies [J].
Bretz, F ;
Pinheiro, JC ;
Branson, M .
BIOMETRICS, 2005, 61 (03) :738-748
[3]   Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial [J].
Cadavid, Diego ;
Mellion, Michelle ;
Hupperts, Raymond ;
Edwards, Keith R. ;
Calabresi, Peter A. ;
Drulovic, Plena ;
Giovannoni, Gavin ;
Hartung, Hans-Peter ;
Arnold, Douglas L. ;
Fisher, Elizabeth ;
Rudick, Richard ;
Mi, Sha ;
Choi, Yi ;
Li, Jie ;
Zhang, Yiwei ;
Cheng, Wenting ;
Xu, Lei ;
Zhu, Bing ;
Green, Susan M. ;
Chang, Ih ;
Deykin, Aaron ;
Sheikh, Sarah, I .
LANCET NEUROLOGY, 2019, 18 (09) :845-856
[5]  
Fraser G., 2019, J ENDOCRINE SOC, V3, pOR33
[6]  
Grignolo A., 2016, Applied Clinical Trials, V25, P36
[7]   An adaptive design for identifying the dose with the best efficacy/tolerability profile with application to a crossover dose-finding study [J].
Ivanova, Anastasia ;
Liu, Ken ;
Snyder, Ellen ;
Snavely, Duane .
STATISTICS IN MEDICINE, 2009, 28 (24) :2941-2951
[8]  
JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133
[9]  
Musuamba FT, 2017, CPT-PHARMACOMET SYST, V6, P418, DOI 10.1002/psp4.12196
[10]  
O'Neill RT, 2008, DRUG INF J, V42, P235, DOI 10.1177/009286150804200305